UNIVERSITY OF WASHINGTON
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma
- Conditions
- Nodal Marginal Zone B-cell LymphomaPeripheral T-cell LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Adult Grade III Lymphomatoid GranulomatosisRecurrent Adult Hodgkin LymphomaRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Adult Lymphoblastic Lymphoma
- Interventions
- Biological: filgrastimProcedure: leukapheresisOther: laboratory biomarker analysisOther: flow cytometry
- First Posted Date
- 2010-04-26
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 43
- Registration Number
- NCT01110135
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Subjective Analgesic Effects of Naloxone and Virtual Reality
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2012-08-21
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 50
- Registration Number
- NCT01105871
- Locations
- 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
- Conditions
- Hereditary Breast/Ovarian Cancer - BRCA2Estrogen Receptor-negative Breast CancerHereditary Breast/Ovarian Cancer - BRCA1Male Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast CancerRecurrent Breast CancerStage IV Breast CancerTriple-negative Breast Cancer
- Interventions
- Other: laboratory biomarker analysisOther: pharmacological study
- First Posted Date
- 2010-04-15
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 50
- Registration Number
- NCT01104259
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromesRefractory Anemia With Excess BlastsUntreated Adult Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2010-04-12
- Last Posted Date
- 2017-10-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 50
- Registration Number
- NCT01101880
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
🇺🇸Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸Stanford University, Stanford, California, United States
Self-collected Swabs for HPV Testing in 18-24 Year Old Women
- Conditions
- Papillomavirus Infections
- First Posted Date
- 2010-04-12
- Last Posted Date
- 2011-02-14
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 150
- Registration Number
- NCT01101828
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Virtual Reality Hypnosis for Chronic Pain Reduction
- Conditions
- Burns
- Interventions
- Behavioral: Virtual Reality Distraction for Chronic PainBehavioral: Virtual Reality Hypnosis for chronic pain
- First Posted Date
- 2010-04-07
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 10
- Registration Number
- NCT01099657
- Locations
- 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
Depression Attention for Women Now (The DAWN Study)
- Conditions
- Depressive Disorder
- Interventions
- Behavioral: Depression Care Management
- First Posted Date
- 2010-03-31
- Last Posted Date
- 2016-02-04
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 205
- Registration Number
- NCT01096316
- Locations
- 🇺🇸
Women's Clinic at Harborview Medical Center, Seattle, Washington, United States
🇺🇸Women's Health Care Center at University of Washington Medical Center (Roosevelt Clinic), Seattle, Washington, United States
A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: 100 mg/m2 doseDrug: 200 mg/m2 dose
- First Posted Date
- 2010-03-26
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 20
- Registration Number
- NCT01093521
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸University of Washington, Seattle, Washington, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
Fat Effects in Women With Metabolic Syndrome
- Conditions
- Metabolic Syndrome
- Interventions
- Dietary Supplement: fat feeding
- First Posted Date
- 2010-03-26
- Last Posted Date
- 2011-08-05
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 10
- Registration Number
- NCT01093560
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Study of Cimzia for the Treatment of Ulcerative Colitis
- First Posted Date
- 2010-03-19
- Last Posted Date
- 2021-12-14
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 27
- Registration Number
- NCT01090154
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States